Latest Breaking News On - Hedge funds weigh in on eyepoint pharmaceuticals - Page 1 : comparemela.com

EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Receives Consensus Recommendation of Buy from Analysts

EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Receives Consensus Recommendation of Buy from Analysts
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdYork mellon corpEyepoint pharmaceuticals company profileSecurities exchange commissionEyepoint pharmaceuticals stockJpmorgan chase coAnalyst recommendations for eyepoint pharmaceuticalsInsider activity at eyepoint pharmaceuticalsEyepoint pharmaceuticals incEyepoint pharmaceuticalsHedge funds weigh in on eyepoint pharmaceuticalsMirae asset global investments coNews ratings for eyepoint pharmaceuticals dailyJump financialTd asset management incGet free report

EyePoint Pharmaceuticals (NASDAQ:EYPT) Price Target Cut to $38 00 by Analysts at Robert W Baird

EyePoint Pharmaceuticals (NASDAQ:EYPT) Price Target Cut to $38 00 by Analysts at Robert W Baird
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdChina universal asset management coInvestment advisersJpmorgan chase coAnalyst recommendations for eyepoint pharmaceuticalsEyepoint pharmaceuticals incEyepoint pharmaceuticals tradingTower research capitalEyepoint pharmaceuticals company profileSecurities exchange commissionHedge funds weigh in on eyepoint pharmaceuticalsSherbrooke park advisersNews ratings for eyepoint pharmaceuticals dailyToth financial advisory corpEyepoint pharmaceuticalsGet free report

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down to $19 74

Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $19.74, but opened at $13.89. EyePoint Pharmaceuticals shares last traded at $12.99, with a volume of 4,364,816 shares traded. Analyst Upgrades and Downgrades A number of equities research analysts have […]

Securities exchange commissionCapstone investment advisorsEyepoint pharmaceuticalsEyepoint pharmaceuticals price performanceEssex investment management coNews ratings for eyepoint pharmaceuticals dailyChina universal asset management coEyepoint pharmaceuticals incWoodstock corpJpmorgan chase coHedge funds weigh in on eyepoint pharmaceuticalsJanney montgomery scottGet free reportPoint pharmaceuticalsOne financialCormorant asset management

Cormorant Asset Management, Lp Acquires 581,765 Shares of EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Stock

Cormorant Asset Management, Lp Acquires 581,765 Shares of EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China universal asset management coSecurities exchange commissionQuarter for eyepoint pharmaceuticalsJpmorgan chase coEyepoint pharmaceuticals incNews ratings for eyepoint pharmaceuticals dailySherbrooke park advisersEyepoint pharmaceuticals price performanceTower research capitalEyepoint pharmaceuticalsInvestment advisersHedge funds weigh in on eyepoint pharmaceuticalsToth financial advisory corpGet free reportCormorant asset managementExchange commission

Cormorant Asset Management, Lp Buys 581,765 Shares of EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Stock

Cormorant Asset Management, Lp Buys 581,765 Shares of EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hermes incFranklin resources incEyepoint pharmaceuticalsEyepoint pharmaceuticals company profileHedge funds weigh in on eyepoint pharmaceuticalsFirst turn managementJennison associatesJpmorgan chase coEyepoint pharmaceuticals incNews ratings for eyepoint pharmaceuticals dailySecurities exchange commissionQuarter for eyepoint pharmaceuticalsEyepoint pharmaceuticals stock performanceGet free reportCormorant asset managementExchange commission